129 publications.
Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies
Adams D, Hurson AN, Ahearn TU, Andrulis IL, Antoniou AC, Auvinen P, Bane A, Behrens S, de Gonzalez AB, Białkowska K
High-Risk Benign Breast Lesions: An Ontario Health (Cancer Care Ontario) Recommendations Report
Eisen A, Bane A, Causer P, Cordeiro E, Fienberg S, Kornecki A, Kulkarni A, Hong NL, Mancuso T, Muradali D
Prognostic and predictive capacity of tumor infiltrating lymphocytes in the MA.20 regional node radiotherapy trial
Riaz N, Chen BE, Bane A, Gao D, Stovgaard ES, Kos Z, Leung SC, Shenasa E, Parulekar W, Chambers S
Canadian Recommendations on Optimal Breast Biopsy Practices Developed Using a Modified Delphi Panel
Kellow ZS, Alikhassi A, Bane A, Bissell MB, Cordeiro E, Dhamanaskar K, Jessup J, Kirwan RC, Ko G, Kos Z
The Significance of Thyroid Hormone Receptors in Breast Cancer: A Hypothesis-Generating Narrative Review
Quan T, Cockburn J, Dhesy-Thind S, Bane A, Leong H, Geleff C, Devion C, Ajel N, Jerzak KJ
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer
Chang L, Smith S, Bane A, Stevens C, Bowen J, Provencher S, Théberge V, Akra MA, Voduc KD, Whelan TJ
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
O’Mahony DG, Ramus SJ, Southey MC, Meagher NS, Hadjisavvas A, John EM, Hamann U, Imyanitov EN, Andrulis IL, Sharma P
Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force
Faragalla H, Plotkin A, Barnes P, Lu F-I, Kos Z, Mulligan AM, Bane A, Mozes SN
Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial
Nielsen TO, Leung SCY, Riaz N, Mulligan AM, Kos Z, Bane A, Whelan TJ
Abstract P4-02-16: Prognostic and Predictive Capacity of Tumor Infiltrating Lymphocytes in the MA.20 regional radiotherapy trial
Riaz N, Chen B, Bane A, Gao D, Stovgaard E, Kos Z, Leung S, Shenasa E, Parulekar W, Chambers S
Frequent collaborators
30- Oncology
- Pathology & Molecular Medicine
- Medicine
- Medical Imaging
- Biochemistry & Biomedical Sciences
- Family Medicine
Co-authors at McMaster University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Gregory Pond
Oncology
22 shared papers, latest 2023
Timothy Whelan
Oncology
19 shared papers, latest 2025
Mark Norman Levine
Oncology
18 shared papers, latest 2023
John Algernon Hassell
Biochemistry & Biomedical Sciences
14 shared papers, latest 2018
Sukhbinder Dhesy-Thind
Oncology
9 shared papers, latest 2024
Sameer Parpia
Oncology
8 shared papers, latest 2023
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.